Collagen Paste Injection in Crohn's Disease Perianal Fistula: Long-term Outcomes of a Pilot, Prospective Cohort Study
The results suggest that collagen paste injection may represent a safe and effective option for Crohn's perianal fistulas, worth further investigation in larger trials.
Authors
- Annalisa Maroli (ORCID: https://orcid.org/0000-0002-7576-9629)
- Antonino Spinelli (ORCID: https://orcid.org/0000-0002-1493-1768)
- Arianna Dal Buono (ORCID: https://orcid.org/0000-0002-8543-4355)
- Roberto Gabbiadini (ORCID: https://orcid.org/0000-0002-7277-1053)
- Caterina Foppa (ORCID: https://orcid.org/0000-0001-9920-0368)
- Michele Carvello (ORCID: https://orcid.org/0000-0002-8650-2321)
- Alessandro Armuzzi (ORCID: https://orcid.org/0000-0003-1572-0118)
- Carlotta La Raja (ORCID: https://orcid.org/0000-0003-4338-596X)
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Journal of the Anus Rectum and Colon
- Published
- 2024-10-24
- DOI
- https://doi.org/10.23922/jarc.2024-008
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Gilead Sciences
- Biogen
- Celgene
- Stryker
- Mylan
- Celltrion
- Samsung
- Allergan